MAILING LIST
  • Extractables & Leachables Europe
  • Extractables & Leachables Asia
  • Extractables and Leachables USA

Extractables & Leachables Europe

2025 to be announced
Location to be announced

Extractables & Leachables Europe is the world's leading conference dedicated solely to extractables and leachables. 

Smithers has accumulated more than four decades of expertise in organising global events and  curating enlightening and informative conferences that offer valuable networking prospects. With speakers from distinguished companies like Element, GSK Vaccines, Aptar Pharma, Octapharma, Sartorius Stedim Biotech and numerous others, the agenda is bursting with insights, helping the 2023 E&L Europe conference be the most exceptional one to date. 

The event spans over two days and includes a series of presentations on industry insights and collaborative discussions, making it an indispensable gathering for professionals working within the industry.

2023 conference highlights:

We explored topics such as best practise and regulations, E&L case studies, interactions of E&L, Medical Devices, toxicology, single-use systems, analytical chemistry.

We heard presentations from GlaxoSmithKline, FILAB, GSK, Smithers, Sartorius Stedim Biotech, Aptar Pharma, Lausanne University, Eurofins, Lonza, Akron, Element, PerkinElmer, NAMSA, Novo Nordisk, Instem, WuXi AppTec, Octapharma, NIBRT, Cytiva, Sartorius Stedim Biotech, PPD, A&M and Nelson Labs.

Attended by CEO's, senior principal scientists, researchers, presidents, chemistry directors, lecturers, R&D managers and pharmacologists to name a few.

 

Supported by:


 


"Beyond all my expectations - this conference has significantly improved my knowledge of E&L"
- Quality Systems Specialist, Becton Dickinson


2024 Agenda

View Full Agenda
Spaces are limited, to sign up for this workshop please email Sharleen at slabonte@smithers.com
Toxicological Risk Assessment of Medical Device Materials
Registration and welcome refreshment
SESSION 1: ANALYTICAL CHEMISTRY
SESSION 2: E&L CASE STUDIES & SINGLE-USE SYSTEMS
SESSION 3: REGULATIONS
Chair’s conference summary
Networking Drink Reception
Registration & Welcome Refreshments
SESSION 4: TOXICOLOGY
SESSION 5: MEDICAL DEVICES & COMBINATION PRODUCTS
Chair's closing remarks and end of conference
Pete Watts - Bibra toxicology advice & consulting

Pete Watts

Toxicology Director at Bibra toxicology advice & consulting
Tarja Nurmi - Bayer

Tarja Nurmi

Senior Expert, Extractables & Leachables at Bayer
Davide Angelini - Eurofins BioPharma Product Testing Italy

Davide Angelini

Extractables & Leachables – Project Leader at Eurofins BioPharma Product Testing Italy
Céline Turminel - Novartis Pharmaceutical Manufacturing GmbH

Céline Turminel

Expert Science & Technology at Novartis Pharmaceutical Manufacturing GmbH
Alina Martirosyan - B. Braun Melsungen AG

Alina Martirosyan

Sr. Scientific Manager Toxicology at B. Braun Melsungen AG
Berk Oktem PhD DABT - U.S. Food and Drug Administration

Berk Oktem PhD DABT

Chemist, Center for Devices and Radiological Health at U.S. Food and Drug Administration
Bibra toxicology advice & consulting
Cytiva
ELSIE
Eurofins BioPharma Product Testing
Element
Intertek

2024 Advisory Board

Carsten Worsøe - Novo Nordisk

Carsten Worsøe

Principal Scientist Extractables and Leachables at Novo Nordisk
Dr. Cheryl Stults - C&M Technical Consulting

Dr. Cheryl Stults

Principal at C&M Technical Consulting
Michael Creese - Smithers

Michael Creese

Operations Director of Chemistry Medical Device Testing at Smithers
Thomas Egert - Boehringer Ingelheim Pharmaceuticals

Thomas Egert

Analytical Development at Boehringer Ingelheim Pharmaceuticals
Ronald Brown - Risk Science Consortium, LLC & US FDA(Retired)

Ronald Brown

Toxicologist at Risk Science Consortium, LLC & US FDA(Retired)
Alicja Sobańtka PhD - Octapharma

Alicja Sobańtka PhD

Head of Corporate Material Qualification at Octapharma

"E&L Europe continues to grow and is clearly the premier event of its type "
- Executive Partner, SCIO Analytical